Your browser doesn't support javascript.
loading
Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies-Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus.
Fischer, Katarzyna; Przepiera-Bedzak, Hanna; Brzosko, Iwona; Sawicki, Marcin; Walecka, Anna; Brzosko, Marek.
Afiliação
  • Fischer K; Individual Laboratory for Rheumatologic Diagnostics, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Przepiera-Bedzak H; Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Brzosko I; Individual Laboratory for Rheumatologic Diagnostics, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Sawicki M; Department of Imaging Diagnostics and Interventional Radiology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Walecka A; Department of Imaging Diagnostics and Interventional Radiology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Brzosko M; Department of Rheumatology, Internal Medicine, Geriatrics and Clinical Immunology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
Biomolecules ; 12(10)2022 Sep 20.
Article em En | MEDLINE | ID: mdl-36291537

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Raynaud / Hominidae / Síndrome Antifosfolipídica / Aterosclerose / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Raynaud / Hominidae / Síndrome Antifosfolipídica / Aterosclerose / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article